The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021080 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giorgio Maria Baldini und 6 weiteren Autor:innen. Beteiligte Einrichtung: IVF Center, Momo Fertilife, 76011 Bisceglie, Italy. Hauptthemen laut MEDLINE: Ovarian Follicle, Receptors, FSH. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
After the controlled ovarian stimulation (COS), the number of cumulus oocyte complexes collected is lower than predicted. The aim of this study is to understand if there is a possible reason for that deficient ovarian response. It was hypothesized that this is associated with the SNP (single-nucleotide polymorphism) of the FSH receptor (FSHr), specifically c.2039A > G, resulting in Asn680Ser. Two groups of patients were enrolled for this purpose: the normal (n = 36) and abnormal responses (n = 31). To predict the number of retrievable oocytes, according to the anti-Mũllerian hormone (AMH) and the antral follicle count (AFC), the following formula was applied in a log scale: the number of oocytes retrieved = 2.584 − 0.015 × (age) − 0.035 × (FSH) + 0.038 × (AMH) + 0.026 × (AFC). Then, when the number of oocytes collected was less than 50% of the calculated value, it was proposed that the patients result in an abnormal response. DNA sample blood was collected from the women, and then the genetic assessment for the Asn680Ser of the FSHr was evaluated in both groups. The differences between the two categories were statistically analyzed with an independent samples t test, a Mann–Whitney U test and a Chi-squared test. In a patient with an abnormal response, a significant prevalence of the amino acid serine at position 680 of the FSHr compared to the counterpart group (p < 0.05) was detected. In conclusion, according to the results, the genetic evaluation of the FSHr could represent an accurate and predictive feature for patients undergoing assisted reproductive technology treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IVF Center, Momo Fertilife, 76011 Bisceglie, Italy.
- Department of IVF, "San Giorgio" Hospital-AUSL Romagna, 47841 Cervia, Italy.
- Edinburgh Fertility Reproductive Center, Royal Infirmary Edinburgh, Edinburgh EH16 4SA, UK.
- Department of Biomedical Sciences and Human Oncology, Obstetrics and Gynaecology Section, Univesity of Bari, 70121 Bari, Italy.
- Clinic of Obstetrics and Gynecology "Santa Caterina Novella", Hospital Galatina, 73013 Galatina, Italy.
ORCID-Profile: Giorgio Maria Baldini, Assunta Catino, Simone Palini, Daniele Ferri, Domenico Baldini
Zitieren
APA
Baldini, G. M., Catino, A., Palini, S., Sciorio, R., Ferri, D., Vinciguerra, M., & Baldini, D. (2023). The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021080
Vancouver
Baldini GM, Catino A, Palini S, Sciorio R, Ferri D, Vinciguerra M, et al. The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021080
BibTeX
@article{Baldini2023,
author = {Baldini, Giorgio Maria and Catino, Assunta and Palini, Simone and Sciorio, Romualdo and Ferri, Daniele and Vinciguerra, Marina and Baldini, Domenico},
title = {The Polymorphism Asn680Ser on the FSH Receptor and Abnormal Ovarian Response in Patients with Normal Values of AMH and AFC},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021080}
}
EUVIMED